PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling
- 1 January 2019
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 450, 132-143
- https://doi.org/10.1016/j.canlet.2019.02.040
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81702936, 81822037, 81472589, 81672602, 81402345, 81502264, 81872090)
- Natural Science Foundation of Beijing (7172199)
- Postdoctoral Science Foundation of China (2017M613389, 2018T111142)
- Logistics Scientific Research Project (BWS16J010)
- Capital Foundation of Medical Developments (2016-4-5061)
This publication has 42 references indexed in Scilit:
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaGenome Research, 2013
- Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?Cancer Research, 2012
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- Focal adhesion kinase and its signaling pathways in cell migration and angiogenesisAdvanced Drug Delivery Reviews, 2010
- Mammary Epithelial-Specific Ablation of the Focal Adhesion Kinase Suppresses Mammary Tumorigenesis by Affecting Mammary Cancer Stem/Progenitor CellsCancer Research, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- The role of focal-adhesion kinase in cancer — a new therapeutic opportunityNature Reviews Cancer, 2005
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomasHepatology, 2003